AFP and hepatocellular carcinoma: By applying a machine learning approach, the random survival forest model, the present study demonstrated that the BCLC stage, tumor size, alpha-fetoprotein level, ALBI grade, number of lesions, and number of lobes involved were independent risk factors associated with one-year disease control for unresectable HCC treated with TACE combined with sorafenib.